Clinical Trial Update: 18-F Sodium Fluoride (18F-NaF) PET for the Assessment of Bioprosthetic Aortic Valve Durability and Outcomes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial using 18F-NaF PET imaging to assess bioprosthetic aortic valve durability and outcomes in patients with aortic stenosis; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• 18F-NaF (sodium fluoride labeled with fluorine-18)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Aortic Stenosis | Phase 2 | Status: COMPLETED